FindTrial
Sign In

Study to compare the effect of fentanyl and dexmedetomidine when added to 0.5% Bupivacaine in brachial plexus block for upper limb surgeries

CLINICAL STUDY TO COMPARE THE EFFECT OF FENTANYL AND DEXMEDETOMIDINE AS AN ADJUVANT TO 05% BUPIVACAINE IN NERVE STIMULATOR GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERIES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047044
Enrollment
90
Registered
2022-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S510- Open wound of elbow Health Condition 2: S529- Unspecified fracture of forearm Health Condition 3: S629- Unspecified fracture of wrist andhand

Interventions

Control Intervention1: Dexmedetomidine: 0.5% bupivacaine hydrochloride 30 ml to which 1μg/kg Dexmedetomidine will be added and given for supraclavicular brachial plexus block before the start of Sur

Sponsors

Madiha Mehmood Ansari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age18 years - 60 years - ASA grade 1 and 2 - Scheduled for elective upper limb surgeries under supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria: Lack of patientâ??s consent. - Age 60yrs.- ASA grade 3 and more. - History of serious pulmonary disease, ischemic heart disease, renal/hepaticdysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile. - Patient with h/o opioid abuse. - Patients with local skin site infections. - Patients with hypersensitivity to any of the drugs used. - Pregnant and lactating mothers. - Failure of Block - Restricted neck movement.

Design outcomes

Secondary

MeasureTime frame
To compare side effects of 0.5% Bupivacaine with dexmedetomidine, 0.5% Bupivacaine with fentanyl and 0.5% Bupivacaine innerve stimulator guided supraclavicular brachial plexus block.Timepoint: First 24 hours at 5 mins, 10 mins, 15 mins, 30 mins, 1 hour, 2 hour, 4 hours, 6 hours, 12 hours and 24 hours—

Primary

MeasureTime frame
To compare the efficacy of 0.5% Bupivacaine with dexmedetomidine, 0.5% Bupivacaine with fentanyl and 0.5% Bupivacaine innerve stimulator guided supraclavicular brachial plexus block.Timepoint: First 24 hours at 5 mins, 10 mins, 15 mins, 30 mins, 1 hour, 2 hour, 4 hours, 6 hours, 12 hours and 24 hours—

Countries

India

Contacts

Public ContactMadiha Mehmood Ansari

Peoples College of Medical Science and research centre, Bhanpur, Bhopal.

ph.anaesthsia@peoplesuniversity.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026